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Abstract 
Background: In Ethiopia, where malaria and schistosomiasis are co-endemic, co-infections are expected to be high. 
However, data about the prevalence of malaria-schistosomiasis co-infection and their clinical correlation is lacking. 
Therefore, the aim of this study was to assess prevalence of Schistosoma mansoni co-infection and associated clinical 
correlates in malaria patients.
Methods: A cross-sectional study was conducted in 2013 at Chwahit Health Center, in northwest Ethiopia. Blood film 
positive malaria patients (N = 205) were recruited for the study. Clinical, parasitological, hematological, and biochemi-
cal parameters were assessed from every study participant. Stool samples were also collected and processed with 
Kato-Katz technique to diagnose and classify intensity of Schistosoma mansoni.
Results: The prevalence of Schistosoma mansoni and malaria co-infection was 19.5 %. The age group of 16–20 years 
old was significantly associated with co-infection. Co-infected patients with a moderate-heavy egg burden of Schisto-
soma mansoni had significantly high mean Plasmodium parasitemia. On the other hand, age group of 6–10 years old 
and moderate-heavy Schistosoma mansoni co-infection were significantly associated with severe malaria.
Conclusions: Prevalence of malaria and Schistosoma mansoni co-infection in the study area was considerably high. 
Severity of malaria and parasitemia of Plasmodium were associated with certain age groups and intensity of concur-
rent Schistosoma mansoni. Further study is needed to explore the underlying mechanisms of interaction between 
malaria and Schistosoma mansoni.
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Background
Malaria is a complex and deadly parasitic disease caused 
by genus Plasmodium. Plasmodium falciparum (P. fal-
ciparum) and Plasmodium vivax (P. vivax) are the pre-
dominant species globally attributing to the majority 
of disease burden. According to World Malaria Report 
2013, there were an estimated 207 million episodes and 
627,000 deaths due to malaria in 2012, of which approxi-
mately 80 % of the episodes and 90 % of the deaths were 
in the Africa region. Approximately, 77  % of malaria 
deaths globally occurred among children under 5  years 
[1].
Malaria is a major public health burden in Ethio-
pia, where its transmission and burden varies with alti-
tude, degree of urbanization, and use of insecticides [2]. 
A recent malaria trend analysis in northwest Ethiopia 
revealed 40  % prevalence; the only species to cause the 
disease, as confirmed microscopically, were P. falciparum 
(75 %) and P. vivax (25 %) [3].
Open Access
*Correspondence:  sisaygetie@yahoo.com 
1 Department of Medical Parasitology, School of Medicine and Health 
Sciences, College of Medicine and Health Sciences, University of Gondar, 
Gondar, Ethiopia
Full list of author information is available at the end of the article
Page 2 of 6Getie et al. BMC Res Notes  (2015) 8:480 
In tropical African countries, epidemiological concur-
rence and co-infection between malaria and helmin-
thiasis is common [4–6]. For example, in Tanzania the 
prevalence of malaria-schistosomiasis co-infection was 
reported to be 42  % [4]. In Ethiopia, the prevalence of 
malaria-schistosomiasis co-infection reported to be 15 % 
and caused high prevalence of anemia, as compared to 
those infected only with malaria [6].
Earlier studies indicated a controversial interaction 
of helminthic co-infection with malaria [7, 8]. Intesti-
nal schistosomiasis plays an antagonistic role against 
malaria, but the egg intensity of Schistosoma mansoni 
(S. mansoni) and the age of infected individuals could 
determine the type of interaction [9, 10]. Although 
most studies were conducted on animal models, they 
reported that S. mansoni co-infection contributes to 
severe malaria presentation. They revealed that S. man-
soni co-infection resulted in high Plasmodium para-
sitemia and increased susceptibility of infected mouse 
models to mortality [11–14]. In contrast, others illus-
trated that S. mansoni co-infection contributed to low 
Plasmodium parasitemia and inhibited cerebral malaria 
[15–17]. However, these studies suggested that the type 
of animal model and Plasmodium parasite used signifi-
cantly affects the impact of S. mansoni co-infection with 
malaria.
On the other hand, a study among humans revealed 
the association between heavy Plasmodium parasitemia 
and heavy intensity schistosomiasis co-infection [18]. In 
order to put better clinical management and control of 
malaria, especially in schistosomiasis co-endemic areas, 
information on the prevalence and clinical outcomes 
of schistosomiasis co-infection with malaria is needed. 
Therefore, this study was aimed to assess the prevalence 
of intestinal S. mansoni and malaria co-infection and 




The study was conducted at Chwahit Health Center, 
Northwest Ethiopia. Chwahit is located at 12°20ʹ4ʺN and 
37°13ʹ35ʺE and at an elevation of 1837 m above sea level. 
There was one health center providing health care for 
about 30,000 people in Chwahit and its surrounding. As 
reported by the District Health Bureau, malaria (due to 
P. falciparum and P. vivax) and schistosomiasis (due to S. 
mansoni) are common in the study area.
Study design, period and participants
A cross-sectional study was conducted from February 
to May 2013 among microscopically confirmed malaria 
patients attending Chwahit Health Center.
Inclusion criteria
Microscopically confirmed malaria patients who pro-
vided both blood and stool samples were enrolled in the 
study.
Exclusion criteria
Patients who attended antiretroviral therapy and ante-
natal outpatient departments, and patients who had 
confirmed chronic diseases and concurrent intestinal 
helminths other than S. mansoni were excluded from 
participation.
Sample size and sampling techniques
Single population proportion formula was used. Assum-
ing 15 % of malaria and S. mansoni co-infection [6], 95 % 
level of significance, 5 % precision and 5 % non response 
rate, a total of 205 study participants were recruited using 
a random sampling technique.
Data collection procedures
Demographic and clinical data
An interview-based questionnaire was used to collect 
demographic data, and clinical data was collected dur-
ing physical examination at the outpatients’ department 
of the Health Centre. Severe malaria, in this study, was 
defined as: P. falciparum positive patients who presented 
with either circulatory collapse (a systolic pressure of less 
than 80  mmHg in adults and <50  mmHg in children), 
severe anemia less than 5 mg/dl, hypoglycemia less than 
40 mg/dl, or hyper-parasitemia (≥100,000 parasites/μl of 
whole blood) [19].
Microscopic determination of Plasmodium parasitemia
Two drops of venous blood were placed separately on a 
microscopic glass slide. Thick and thin blood films were 
prepared and air dried. Thin blood films were fixed with 
absolute methanol and both films were stained with 
10  % Geimsa working solution for 10  min. Then both 
thin and thick blood films were read by an experienced 
malaria microscopist with a 100× objective lens and 
100 microscopic fields examined to rule out the absence 
of the malaria parasite. Malaria parasitemia was deter-
mined in thick blood films along with 200 white blood 
cells.
Determination of hematological parameters
Three milliliters venous blood was collected with tris-
potassium ethylene diamine tetra acetic acid (EDTA) 
anti-coagulated tube. Blood was analysed by Cell Dyne 
1800 (Abbot Hematology, IL, USA) for the determination 
of total white blood cells, granulocytes, lymphocytes, 
mixed cells, red blood cells, platelets, and hemoglobulin 
level.
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Serum biochemical analysis
Three milliliters venous blood was collected with non-
anticoagulated tube and allowed to clot at bench top. 
Then, blood centrifuged at 3000 revolution per minute 
for 4  min and serum was aliquoted. Then, serum was 
analysed by HumaStar chemistry analyzer (Human Diag-
nostics, USA) for serum level of serum glutamate pyru-
vate transaminase (SGPT), serum glutamate oxaloacetate 
transaminase (SGOT), total protein, and glucose.
Microscopic diagnosis of Schistosoma mansoni
One gram of fresh stool sample was collected from every 
study participant. Stool samples were processed with 
Kato-Katz technique using standardized template meas-
uring 41.75  mg of stool to prepare smear for detection 
and count of S. mansoni ova. The egg load of S. mansoni 
from stool was classified as light [1–100 egg/gram (epg)], 
medium (101–400 epg), or heavy (>400 epg) [20].
Statistical analysis
Data entered into computer data base using Epi Info 
3.5.3. Cleared data was transferred to SPSS version 20 
for statistical analysis using logistic regression, independ-
ent samples t test and one way ANOVA. Odds ratio (OR) 
with 95 % CI was used to determine strength of associa-
tion between variables. Statistically significance was con-
sidered at 95 % level of confidence and P value less than 
0.05.
Ethical considerations
The study protocol was reviewed and approved by 
School of Biomedical and Laboratory Sciences Research 
and Ethics Committee, University of Gondar, Gondar, 
Ethiopia. Permission was obtained from Dembia Health 
Bureau and Chwahit Health Center to conduct the study. 
Informed consent and assent were obtained from all par-
ticipants and/or their guardians after being briefed on the 
risks and benefits of the study.
Results
Demographic and clinical characteristics of the study 
participants
A total of 205 malaria positive study participants, 63.4 % 
(130/205) males and 36.6  % (75/205) females, were 
included. The mean (SD) age of study participants was 
25 (12) years. The prevalence of P. falciparum and P. 
vivax among the study participants was 71.7 % (147/205) 
and 25.9  % (53/205), respectively. The remaining 2.4  % 
(5/205) had mixed infections. Fifty six percent (115/205) 
of the study participants presented with fever. Hypoten-
sion was found only among 2.9 % (6/205) of the partici-
pants. Severe malaria was observed in 25  % (38/152) of 
the study participants, while hyper-parasitemia was 
identified in only 3.9 % (6/152) of the study participants 
harboring P. falciparum.
Prevalence of malaria and S. mansoni co‑infection
In this study, the prevalence of S. mansoni and malaria 
co-infection was 19.5 % (40/205). Eighty percent of the S. 
mansoni co-infections were observed in participants with 
P. falciparum, while the remaining 20 % were within those 
with P. vivax infection. A higher percentage of S. mansoni 
co-infection [32.5 % (13/40)] was observed within the age 
group of 16–20 years old (p < 0.05) (Table 1).
Clinical correlates of malaria and S. mansoni co‑infection
In this study, there was a higher frequency of fever 
among S. mansoni co-infected participants than malaria 
only infected ones (χ2 =  5.43, P < 0.022). A higher fre-
quency of severe anemia was also observed among S. 
mansoni co-infected participants (35.0  %) than malaria 
only infected ones (25.5 %) (χ2 = 7.54, P < 0.006).
In addition, mean differences in hematological and 
biochemical parameters were observed among S. man-
soni co-infected and malaria only infected participants. 
However, a significant difference was observed only in 
mean red blood cell count (4.42 ± 0.11 vs. 4.64 ± 0.04, 
p  <  0.033) and hemoglobulin level (12.48  ±  0.38 vs. 
13.38 ± 0.13, p < 0.006), respectively (Tables 2, 3).
Table 1 Logistic regression for risk of S. mansoni co-infec-
tion among  study participants at  Chwahit Health Center, 
Northwest Ethiopia, 2013
β coefficient of regression, CI confidence interval
* Statistically significant with p value less than 0.05
Variables Frequency of S. mansoni co‑infection β (95 % CI)





 Male 28 (21.5) 102 (78.5) 1
 Female 12 (16.0) 63 (84.0) 0.686 (0.31–1.516)
Age
 6–10 5 (23.8) 16 (76.2) 2.494 (0.661–9.41)
 11–15 5 (18.2) 21 (80.8) 1.958 (0.52–7.37)
 16–20 13 (26.0) 37 (74.0) 3.04 (1.04–8.94)*
 21–25 6 (20.0) 24 (80.0) 2.22 (0.63–7.83)
 26–30 5 (20.0) 20 (80.0) 1.97 (0.53–7.39)
 30+ 6 (11.3) 47 (88.7) 1.00
Residence
 Urban 6 (13.3) 39 (86.7) 1.00
 Rural 34 (21.4) 126 (78.6) 1.57 (0.58–4.2)
Living nearby swampy area
 Yes 22 (22.7) 75 (77.3) 1.54 (0.73–3.26)
 No 18 (16.7) 90 (83.3) 1.00
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There was a mean difference in malaria parasitemia 
among malaria only infected, light and moderate-heavy 
S. mansoni co-infected participants (F = 3.43, p < 0.034). 
In the Post Hoc analysis, this difference persisted only 
among light and moderate-heavy S. mansoni co-infected 
participants (3224 vs. 5537 parasite/μl, p < 0.027).
In this study, severe malaria was identified in 18.5  % 
(38/205) of the study participants. A higher frequency of 
severe malaria was observed among males (65.8 %) than 
females (34.2 %). Patients in the age group of 6–10 years 
old were 6.8 times more likely to experience severe 
malaria (p < 0.05). Twenty-six percent of the study partic-
ipants with severe malaria had S. mansoni co-infection. 
Moderate-heavy intensity of S. mansoni was associated 
with severe malaria (p < 0.05) (Table 4).
Discussion
Malaria and schistosomiasis co-exist in sub-Saharan Afri-
can countries [4–6, 21]. In the present study, the overall 
prevalence of S. mansoni co-infection with malaria was 
19.5 %. This prevalence was lower compared to a recent 
study carried out in southern Ethiopia, 22.6 % [21], and 
Tanzania 42 % [5]. However, it was higher than another 
study conducted in southern Ethiopia, 15  % [6]. A 
cohort study in Senegal also reported a high co-infection 
between malaria and schistosomiasis [22]. The differ-
ence can be explained by differences in water contact and 
microgeographical areas which could affect the co-infec-
tion between malaria and schistosomiasis [23, 24].
In this study, higher S. mansoni co-infection was 
observed among males and within the age group of 
16–20 years old. In an earlier study from Kenya, children 
were 9.3 times more likely to be co-infected with schis-
tosomiasis and malaria than adults [18]. Additionally, 
studies from Sudan and Swaziland revealed that socio-
cultural factors could lead higher exposure of males for 
schistosomiasis [25–27].
In the current study, a higher frequency of S. man-
soni co-infected participants presented with fever than 
malaria only infected ones. Although each case of malaria 
and schistosomiasis could lead to fever presentation [28, 
29], schistosomiasis co-infection with malaria suggested 
to upregulate production of inflammatory markers that 
aggravate fever [30].
In this study, although significant association was 
found only in red blood cell count and hemoglobulin 
level, hematological parameters were found to be influ-
enced by S. mansoni co-infection. In an earlier animal 
model study, schistosomiasis co-infection prolonged 
lower density malaria parasitemia time and caused ane-
mia as compared to the malaria only infected group [31].
However, P. falciparum and P. vivax were reported 
to decrease hemoglobulin level, white blood cells, red 
blood cells and platelet counts [32]. Schistosomiasis 
could also result in low hemoglobulin level and lym-
phocyte count, but increased total white blood cell, 
neutrophils, eosinophiles and monocytes count [33, 
34]. Therefore, concurrent schistosomiasis with malaria 
could lead to high co-morbidity associated with hema-
tological parameters.
In this study, high mean Plasmodium parasitemia was 
observed more frequently among malaria only infected 
participants than S. mansoni co-infected participants. 
In an earlier study, reduced Plasmodium parasitemia 
Table 2 Independent t test for  blood cells count, mean difference between  S. mansoni co-infected and  malaria only 
infected participants at Chwahit Health Center, Northwest Ethiopia, 2013
Parameters Malaria only infected S. mansoni co‑infected p value
Total white blood cell (×103/μl) 5.81 ± 0.15 5.44 ± 0.24 <0.285
Granulocyte (×103/μl) 3.44 ± 0.12 3.25 ± 0.23 <0.489
Lymphocyte (×103/μl) 1.71 ± 0.06 1.6 ± 0.08 <0.462
Mixed cells (×103/μl) 0.76 ± 0.045 0.59 ± 0.21 <0.062
Red blood cells (×106/μl) 4.64 ± 0.04 4.42 ± 0.11 <0.033
Haemoglobulin (g/dl) 13.38 ± 0.13 12.48 ± 0.38 <0.006
Platelet (×103/μl) 182.4 ± 4.5 190.3 ± 7.8 <0.42
Table 3 Independent t test for  SGOT, SGPT, glucose, total 
protein and  parasitaemia mean difference between  S. 
mansoni co-infected and  malaria only infected partici-
pants at Chwahit Health Center, Northwest Ethiopia, 2013
Parameters Malaria only 
infected
S. mansoni  
co‑infected
p value
SGOT (IU/L) 34.00 ± 2.02 32.06 ± 1.6 <0.64
SGPT (IU/L) 33.5 ± 3.06 30 ± 2.52 <0.58
Glucose (mg/dl) 72.13 ± 1.7 67.92 ± 2.2 <0.24
Total protein (g/dl) 5.78 ± 0.08 5.73 ± 0.16 <0.81
Parasitaemia  
(parasite/μl)
4053 ± 206 3917 ± 393 <0.77
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was reported to be associated with schistosomiasis co-
infection [10]. However, this contradicted a result from 
southern Ethiopia, where schistosomiasis co-infected 
malaria patients were 3.65 times more likely to be Plas-
modium dense than malaria only positives [6]. The differ-
ence could be explained with variation in the intensity of 
schistosomiasis co-infection, which would affect Plasmo-
dium parasitemia.
Higher mean Plasmodium parasitemia was more fre-
quently observed among moderate-heavy S. mansoni 
co-infected participants than light co-infected ones. 
Therefore, schistosomiasis co-infection could affect Plas-
modium parasitemia, depending on the intensity of the 
ova. Previous studies from Mali and Senegal reported 
that light schistosomiasis intensity is correlated with a 
decrease in Plasmodium parasitemia [9, 35].
In the current study, the age group of 6–10 years old 
and moderate-heavy intensity S. mansoni co-infection 
were identified as the determining factors for severe 
malaria. In earlier studies, children co-infected with 
schistosomiasis and heavy intensity of schistosomia-
sis were at risk of developing severe malaria [24, 30, 
35]. This could be explained by the high production of 
interferon gamma (IFN-γ) in children and resulted in 
higher malaria parasitemia that could lead to severe 
malaria [30]. In the present study, 66.7  % of the study 
participants who presented with hyper-parasitemia were 
children.
Conclusions
Prevalence of malaria and S. mansoni in the study area 
was considerably high. Severity of malaria and para-
sitemia of Plasmodium were associated with certain age 
groups and intensity of concurrent intestinal schistoso-
miasis. Further study is needed to explore the underly-
ing mechanisms of interaction between malaria and S. 
mansoni.
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